Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021)

Pharma-Bio Serv's Short term Debt history spans 2 years, with the latest figure at $1.3 million for Q2 2021.

  • For Q2 2021, Short term Debt rose 100.0% year-over-year to $1.3 million; the TTM value through Apr 2021 reached $1.3 million, up 100.0%, while the annual FY2020 figure was $1.3 million, N/A changed from the prior year.
  • Short term Debt reached $1.3 million in Q2 2021 per PBSV's latest filing, roughly flat from $1.3 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.3 million in Q4 2020 to a low of $643900.0 in Q2 2020.